I know prostate cancer is common, but I’m not sure who is most at risk or whether there are symptoms to watch for. When ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by age 85. But the ...

Major technological advances have been made in imaging, especially in the quality of the resolution or detail.

PSA stands for prostate-specific antigen, a protein made by the prostate. A high level can be worrying, but it doesn’t automatically mean prostate cancer. Here’s what men need to know about the test ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

A LUNCH-hour finger-prick test for suspected prostate cancer has been launched. The blood test can assess a man’s level of the cancer marker Prostate Specific Antigen (PSA) in just 10 minutes. Usually ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

Prostate cancer is one of the most common cancers affecting men worldwide, yet it remains surrounded by confusion, myths, and unanswered questions. Many men believe they only need to worry about ...

Men are being offered a £99 prostate cancer test that has been found to detect more than twice as many aggressive cancers as standard screening methods.